Associate Professor
Leiden University Medical Center, Zuid-Holland, Netherlands
Noel de Miranda is a PI of the Cancer Immunogenomics group at the Leiden University Medical Center. His group combines the use of high-end genomic, transcriptomic, and proteomic technologies for the study of cancer genetics and immunology. The main aim of the group is to support the development of novel therapies to enrich the immunotherapy toolbox for the treatment of advanced cancers. The group’s activities are subdivided into two major pillars: 1) the discovery of immunotherapeutic targets in cancer patients that are not amenable to state-of-the-art immunotherapies and 2) the characterization of cancer microenvironments and of immune cell subsets with anti-cancer activity by applying high-dimensional technologies on cancer tissues.
Disclosure information not submitted.
Wednesday, February 9, 2022
1:30 PM – 2:00 PM